Windisch Kyle A, Kosobud Ann E K, Czachowski Cristine L
Department of Psychology, Indiana University-Purdue University, 402 N. Blackford St. LD124, Indianapolis, IN 46202, USA.
Department of Psychology, Indiana University-Purdue University, 402 N. Blackford St. LD124, Indianapolis, IN 46202, USA.
Alcohol. 2014 Aug;48(5):419-25. doi: 10.1016/j.alcohol.2013.12.007. Epub 2014 Apr 21.
Alcohol consumption produces a complex array of effects that can be divided into two types: the explicit pharmacological effects of ethanol (which can be temporally separate from time of intake) and the more temporally "relevant" effects (primarily olfactory and taste) that bridge the time from intake to onset of the pharmacological effects. Intravenous (IV) self-administration of ethanol limits the confounding "non-pharmacological" effects associated with oral consumption, allows for controlled and precise dosing, and bypasses first order absorption kinetics, allowing for more direct and better-controlled assessment of alcohol's effect on the brain. IV ethanol self-administration has been reliably demonstrated in mouse and human experimental models; however, models of IV self-administration have been historically problematic in the rat. An operant multiple-schedule study design was used to elucidate the role of each component of a compound IV-ethanol plus oral-sucrose reinforcer. Male alcohol-preferring P rats had free access to both food and water during all IV self-administration sessions. Animals were trained to press a lever for orally delivered 1% sucrose (1S) on a fixed ratio 4 schedule, and then surgically implanted with an indwelling jugular catheter. Animals were then trained to respond on a multiple FR4-FR4 schedule composed of alternating 2.5-min components across 30-min sessions. For the multiple schedule, two components were used: an oral 1S only and an oral 1S plus IV 20% ethanol (25 mg/kg/injection). Average total ethanol intake was 0.47 ± 0.04 g/kg. We found significantly higher earning of sucrose-only reinforcers and greater sucrose-lever error responding relative to the compound oral-sucrose plus IV-ethanol reinforcer. These response patterns suggest that sucrose, not ethanol, was responsible for driving overall responding. The work with a compound IV ethanol-oral sucrose reinforcer presented here suggests that the existing intravenous ethanol self-administration methodology cannot overcome the aversive properties of ethanol via this route in the rat.
饮酒会产生一系列复杂的效应,这些效应可分为两类:乙醇的明确药理效应(其与摄入时间在时间上可分离)以及在时间上更“相关”的效应(主要是嗅觉和味觉),这些效应连接了从摄入到药理效应开始的时间段。静脉注射(IV)乙醇自我给药限制了与口服相关的混杂“非药理”效应,允许进行可控且精确的给药,并绕过一级吸收动力学,从而能够更直接且更好地控制评估酒精对大脑的影响。静脉注射乙醇自我给药已在小鼠和人类实验模型中得到可靠证明;然而,静脉注射自我给药模型在大鼠中一直存在问题。采用操作性多重时间表研究设计来阐明复合静脉注射乙醇加口服蔗糖强化剂各成分的作用。在所有静脉注射自我给药实验期间,雄性嗜酒P大鼠可自由获取食物和水。动物被训练在固定比率4的时间表上按压杠杆以获取口服的1%蔗糖(1S),然后通过手术植入一根留置颈静脉导管。接着,动物被训练在一个多重FR4 - FR4时间表上做出反应,该时间表由30分钟实验时段内交替的2.5分钟成分组成。对于多重时间表,使用了两个成分:仅口服1S以及口服1S加静脉注射20%乙醇(25毫克/千克/注射)。平均总乙醇摄入量为0.47±0.04克/千克。我们发现,相对于复合口服蔗糖加静脉注射乙醇强化剂,仅蔗糖强化剂的获取量显著更高,且蔗糖杠杆错误反应更多。这些反应模式表明,驱动总体反应的是蔗糖而非乙醇。此处展示的关于复合静脉注射乙醇 - 口服蔗糖强化剂的研究表明,现有的静脉注射乙醇自我给药方法无法通过此途径克服大鼠体内乙醇的厌恶特性。